Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

2(50.0%)

N/A

1(25.0%)

Phase 4

1(25.0%)

4Total

Phase 3(2)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02385279Not ApplicableCompleted

Study Comparing the MiStent SES Versus the XIENCE EES Stent

Role: collaborator

NCT03115281Unknown

Registry to Assess the STENTYS Xposition S for Revascularization of Coronary Arteries In Routine cliNical Practice

Role: lead

NCT01732341Phase 3Terminated

Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction

Role: lead

NCT01538446Phase 4Completed

Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel

Role: collaborator

NCT02800837Unknown

Clinical Study to Evaluate the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease

Role: lead

NCT01008085Phase 3Completed

STENTYS Self-expanding Versus Balloon-expandable Stent in Acute Myocardial Infarction (AMI)

Role: lead

All 6 trials loaded